(Q44293122)

1 December 2017

title

Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF. (English)

1 reference

1 December 2017

main subject

hepatocellular carcinoma

1 reference

Yuan-Yuan Wu

1

1 reference

1 December 2017

Li Chen

2

1 reference

1 December 2017

Gui-Lan Wang

3

1 reference

1 December 2017

Yi-Xin Zhang

4

1 reference

1 December 2017

Jia-Ming Zhou

5

1 reference

1 December 2017

Song He

6

1 reference

1 December 2017

Jing Qin

7

1 reference

1 December 2017

Yuan-Yuan Zhu

8

1 reference

1 December 2017

language of work or name

1 reference

1 May 2013

1 reference

Journal of Molecular Histology

1 December 2017

published in

1 reference

1 December 2017

volume

44

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

433-445

1 reference

Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Gene modulation for treating liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

BCL-2 family members and the mitochondria in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Gene expression property of high-density three-dimensional tissue of HepG2 cells formed in radial-flow bioreactor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Angiopoietin-1 induces sprouting angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Dual gene targeted multimeric siRNA for combinatorial gene silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Dysregulation of apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Sequence and expression of seven new tetraspans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Identification of a new proliferation-associated protein NET-1/C4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10735-012-9480-5

Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma

21 January 2018

1 reference

12 December 2020

CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis

1 reference

12 December 2020

Inhibitory effects of antisense oligodeoxynucleotide on expression of vascular endothelia growth factor by human hepatocarcinoma cells.

1 reference

12 December 2020

The tetraspanin superfamily: molecular facilitators

1 reference

12 December 2020

Suppression of TSPAN1 by RNA interference inhibits proliferation and invasion of colon cancer cells in vitro.

1 reference

12 December 2020

Association of NET-1 gene expression with human hepatocellular carcinoma

1 reference

12 December 2020

Knockdown of TSPAN1 by RNA silencing and antisense technique inhibits proliferation and infiltration of human skin squamous carcinoma cells

1 reference

12 December 2020

Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells

1 reference

12 December 2020

Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.

1 reference

12 December 2020

Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S10735-012-9480-5

Identifiers

DOI

1 reference

1 December 2017

1 reference